Related Experiment Video
Updated: Jun 10, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Adamantinoma‑like Ewing Sarcoma of Head and Neck: A Clinicopathologic Study of Three Cases Including One
Xiang-Nan Gou1, Xia Tian1, Feng-Wei Zhu1
1Department of Pathology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Abstract:
Adamantinoma-like Ewing sarcoma (ALES) is a rare variant of Ewing sarcoma that predominantly occurs in the head and neck region, characterized by epithelial differentiation and overlapping morphology with other small round cell tumors. We present three cases of head and neck ALES (two in the parotid gland and one in the nasal cavity) in patients aged 23-42 years. Histologically, the tumors exhibited a spectrum of features, including small round blue cells and basaloid squamous morphologies. Immunohistochemically, the tumor cells variably expressed CKpan, p63, CD99, NKX2.2, FLI1, CD56, and Syn. The Ki-67 proliferation index ranged widely from 15% to 90%. Notably, one case initially misdiagnosed as squamous cell carcinoma harbored a canonical EWSR1::FLI1 fusion. Crucially, we report the first case of ALES had a negative EWSR1 rearrangement but a somatic NF1 mutation, expanding the molecular spectrum of this entity. Our findings underscore the diagnostic challenge of ALES and highlight the necessity of comprehensive molecular profiling, including next-generation sequencing, for accurate diagnosis and the identification of potential therapeutic targets, particularly in genetically atypical cases.

